UK Drugs in Lactation Advisory Service
Guidance on this new antidepressant added to the database.
General breastfeeding guidance
The risks of exposing an infant to a drug via breast milk can be minimised by both health professionals and mothers if some general principles are followed. This guidance should be followed whenever a medicine is being considered for a mother who is breastfeeding her infant, whether the medicine is prescribed or purchased over-the-counter.
It must also be stressed that the general guidance, and the information provided for individual drugs in the accompanying database, only applies to full-term, healthy infants. Additonal care must be taken, and advice sought, if the infant is pre-term or has compromised health at birth.
Enquiries from healthcare professionals can be made by contacting one of the UKDILAS centres below:
0116 258 6491
0121 424 7298
Alternatively, submit an enquiry via the online enquiry form and your query will be answered as soon as possible.
Database development status
The database includes all drugs used in lactation and has an entry for every drug listed in the BNF.
A. Sections include:
1. Gastrointestinal system
B. Sections under development:
new entries *